Cargando…
COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250838/ https://www.ncbi.nlm.nih.gov/pubmed/37294440 http://dx.doi.org/10.1007/s00277-023-05315-1 |
| _version_ | 1785055843246407680 |
|---|---|
| author | Nachar, Victoria R. Perissinotti, Anthony J. Marini, Bernard L. Karimi, Yasmin H. Phillips, Tycel J. |
| author_facet | Nachar, Victoria R. Perissinotti, Anthony J. Marini, Bernard L. Karimi, Yasmin H. Phillips, Tycel J. |
| author_sort | Nachar, Victoria R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10250838 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102508382023-06-12 COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma Nachar, Victoria R. Perissinotti, Anthony J. Marini, Bernard L. Karimi, Yasmin H. Phillips, Tycel J. Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2023-06-09 /pmc/articles/PMC10250838/ /pubmed/37294440 http://dx.doi.org/10.1007/s00277-023-05315-1 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Nachar, Victoria R. Perissinotti, Anthony J. Marini, Bernard L. Karimi, Yasmin H. Phillips, Tycel J. COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma |
| title | COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma |
| title_full | COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma |
| title_fullStr | COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma |
| title_full_unstemmed | COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma |
| title_short | COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma |
| title_sort | covid-19 infection outcomes in patients receiving cd20 targeting t-cell engaging bispecific antibodies for b-cell non-hodgkin lymphoma |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250838/ https://www.ncbi.nlm.nih.gov/pubmed/37294440 http://dx.doi.org/10.1007/s00277-023-05315-1 |
| work_keys_str_mv | AT nacharvictoriar covid19infectionoutcomesinpatientsreceivingcd20targetingtcellengagingbispecificantibodiesforbcellnonhodgkinlymphoma AT perissinottianthonyj covid19infectionoutcomesinpatientsreceivingcd20targetingtcellengagingbispecificantibodiesforbcellnonhodgkinlymphoma AT marinibernardl covid19infectionoutcomesinpatientsreceivingcd20targetingtcellengagingbispecificantibodiesforbcellnonhodgkinlymphoma AT karimiyasminh covid19infectionoutcomesinpatientsreceivingcd20targetingtcellengagingbispecificantibodiesforbcellnonhodgkinlymphoma AT phillipstycelj covid19infectionoutcomesinpatientsreceivingcd20targetingtcellengagingbispecificantibodiesforbcellnonhodgkinlymphoma |